| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |